Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
NCT05568719
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
173
Enrollment
INDUSTRY
Sponsor class
Conditions
Hemophilia A
Hemophilia B
Interventions
DIAGNOSTIC_TEST:
Testing of hepatic AAV Vector integration
Sponsor
Pfizer